HAMBURG (dpa-AFX) - Evotec AG (EVTCY.PK, EVOTF.PK) a German drug discovery
and development company, announced Wednesday that it has entered into three
novel research projects for the treatment of Multiple Sclerosis or MS supported
BOSTON (MedPage Today) -- Multiple sclerosis patients with larger intracranial volumes -- a measure of their lifetime maximal brain size -- scored better on cognition and physical function tests than those with smaller skull sizes.
BOSTON (MedPage Today) -- An objectively measured sign of spasticity in multiple sclerosis patients was relieved with Sativex, the oromucosal cannabinoid spray, in a small randomized trial reported here.
BOSTON (MedPage Today) -- A biologic drug targeting the granulocyte-macrophage colony stimulating factor was safe and showed hints of activity against brain lesions in multiple sclerosis patients in a phase I trial.
BOSTON (MedPage Today) -- An investigational oral drug for multiple sclerosis with the same mechanism as the approved product fingolimod (Gilenya) was highly effective in a phase II trial with seemingly fewer effects on cardiac function than the...
Partners Biogen Idec and AbbVie are touting late-stage results for their new, monthly multiple sclerosis treatment, preparing to hand in regulatory applications next year and contend in a crowded market.
BOSTON (MedPage Today) -- Daclizumab HYP cut relapse rates and disability progression in multiple sclerosis patients more effectively than interferon beta-1a (Avonex) in a phase III trial, but liver toxicity with the IL-2 inhibitor reared its head...
Oops! Unable to complete your request. Please refresh your browser.